Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
2.17
Dollar change
+0.24
Percentage change
12.44
%
Index- P/E- EPS (ttm)-24.57 Insider Own27.33% Shs Outstand18.38M Perf Week13.61%
Market Cap39.88M Forward P/E- EPS next Y-4.14 Insider Trans54.15% Shs Float13.35M Perf Month9.60%
Income-82.32M PEG- EPS next Q-1.65 Inst Own25.49% Short Float12.96% Perf Quarter-35.22%
Sales80.97M P/S0.49 EPS this Y46.77% Inst Trans-13.71% Short Ratio3.52 Perf Half Y-48.94%
Book/sh27.98 P/B0.08 EPS next Y46.48% ROA-33.03% Short Interest1.73M Perf Year-80.71%
Cash/sh4.07 P/C0.53 EPS next 5Y25.50% ROE-199.90% 52W Range1.24 - 12.75 Perf YTD-27.91%
Dividend Est.- P/FCF- EPS past 5Y9.51% ROI-101.12% 52W High-82.98% Beta1.52
Dividend TTM- Quick Ratio0.89 Sales past 5Y30.43% Gross Margin62.29% 52W Low75.00% ATR (14)0.18
Dividend Ex-Date- Current Ratio1.00 EPS Y/Y TTM-66.07% Oper. Margin-215.16% RSI (14)58.21 Volatility8.31% 10.46%
Employees187 Debt/Eq4.44 Sales Y/Y TTM4.32% Profit Margin-101.67% Recom1.00 Target Price7.50
Option/ShortYes / No LT Debt/Eq3.88 EPS Q/Q-273.64% Payout- Rel Volume0.94 Prev Close1.93
Sales Surprise139.65% EPS Surprise70.68% Sales Q/Q110.26% EarningsNov 14 AMC Avg Volume492.39K Price2.17
SMA207.25% SMA5011.85% SMA200-49.00% Trades Volume469,928 Change12.44%
Date Action Analyst Rating Change Price Target Change
Mar-15-24Resumed ROTH MKM Buy $10
Aug-04-22Initiated Ladenburg Thalmann Buy $6
Oct-02-20Initiated The Benchmark Company Buy $9
Dec-18-19Initiated B. Riley FBR Buy $9
Feb-28-18Initiated B. Riley FBR, Inc. Buy $10
Jul-11-17Initiated Rodman & Renshaw Buy $11
Mar-22-17Initiated JMP Securities Mkt Outperform
Oct-03-16Initiated ROTH Capital Buy $9
Mar-25-24 08:30AM
Mar-22-24 08:30AM
Mar-21-24 04:01PM
Mar-18-24 04:05PM
08:30AM
08:00AM Loading…
08:00AM
Mar-15-24 08:30AM
08:15AM
Mar-13-24 08:30AM
Mar-12-24 08:30AM
Mar-11-24 04:05PM
08:30AM
08:00AM
Mar-07-24 07:30AM
Mar-04-24 08:30AM
08:30AM Loading…
Feb-22-24 08:30AM
Feb-02-24 02:40PM
Jan-29-24 08:00AM
Jan-11-24 08:30AM
08:15AM
08:00AM
Jan-09-24 05:02PM
Jan-05-24 09:15AM
08:30AM
Jan-04-24 08:30AM
Jan-03-24 04:01PM
Jan-02-24 04:05PM
08:30AM
Dec-29-23 08:20AM
Dec-11-23 08:30AM
08:30AM Loading…
Dec-06-23 08:30AM
08:30AM
08:00AM
Dec-05-23 08:30AM
Dec-01-23 08:30AM
Nov-16-23 11:18PM
Nov-14-23 04:29PM
04:10PM
04:05PM
04:01PM
Nov-13-23 05:00PM
04:05PM
Nov-10-23 08:15AM
Nov-09-23 05:05PM
Nov-07-23 04:01PM
Nov-02-23 03:00PM
09:28AM
Oct-31-23 09:15AM
08:30AM
Oct-30-23 02:15PM
Oct-26-23 12:30PM
09:00AM
Oct-20-23 08:30AM
Oct-18-23 08:30AM
Oct-16-23 09:00AM
Oct-09-23 12:50PM
Oct-05-23 08:30AM
Oct-02-23 12:53PM
Sep-21-23 08:30AM
Sep-07-23 08:30AM
08:15AM
Sep-06-23 08:30AM
08:00AM
Sep-05-23 08:30AM
Aug-16-23 08:00AM
Aug-14-23 04:19PM
04:15PM
04:05PM
04:01PM
Aug-10-23 04:15PM
Aug-08-23 04:01PM
Aug-03-23 08:30AM
08:00AM
Aug-02-23 04:01PM
Aug-01-23 02:54PM
08:30AM
Jul-31-23 08:30AM
08:00AM
Jul-27-23 08:30AM
07:00AM
Jul-25-23 08:30AM
Jul-19-23 08:30AM
Jul-11-23 08:30AM
Jul-06-23 08:00AM
Jul-05-23 02:31PM
Jul-03-23 08:00AM
Jun-29-23 08:00AM
Jun-28-23 08:00AM
Jun-15-23 04:01PM
08:00AM
Jun-13-23 08:30AM
Jun-12-23 08:00AM
Jun-08-23 01:18PM
May-23-23 08:30AM
May-22-23 04:01PM
May-19-23 04:01PM
May-18-23 08:03AM
May-15-23 05:15PM
04:15PM
04:15PM
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanJan 05 '24Buy2.3850,000118,7702,863,905Jan 09 08:15 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanNov 14 '23Buy1.701,567,5152,664,7762,597,440Nov 16 05:50 PM
WEISS MICHAEL SSee RemarksNov 14 '23Buy1.70147,058249,9991,130,520Nov 16 05:46 PM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanSep 26 '23Buy0.28100,00028,33015,449,091Sep 27 08:20 AM
Fortress Biotech, Inc.10% OwnerSep 08 '23Buy0.72418,410301,2551,032,390Sep 12 09:02 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanAug 18 '23Buy9.3410,00093,400112,500Aug 21 08:30 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanAug 17 '23Buy11.7510,000117,500102,500Aug 21 08:30 AM